Request for Information (RFI) and Industry Day Announcement: Host-Directed Therapeutics for Prophylaxis, Post-Exposure Prophylaxis and Treatment of Exposure to Viruses, Bacteria and Toxins

This is a Request for Information (RFI) for planning purposes only. It is not to be construed as a commitment by the Government nor will the Government pay for the information solicited. JPM CBRN Medical is hosting an Industry Day 29 October 2024 at the United States Patent and Trademark Office (USPTO) in Alexandria, VA. This event will provide Industry the chance to hear from US Government agencies on current and future work in the arena of Host Directed Therapeutics.

Presentations will be given by JPEO CBRND, BARDA, and JSTO. The following day, 30 October, selected companies can present their product to USG representatives. Those companies will be selected based on responses to this RFI. No solicitation document exists or is guaranteed to be issued as a result of this RFI or in person presentation.

The Joint Project Manager for Chemical, Biological, Radiological, and Nuclear Medical (JPM CBRN Medical) and the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND) is seeking information on the available capabilities and willingness of private entities (academic, non-profit, and commercial) to collaborate with the Government in the areas listed below.

The JPEO-CBRND is interested in late-stage development of host-directed therapeutics or repurposing of United States Food and Drug Administration (FDA) licensed therapeutics that are threat-agnostic with the potential for activity across viral families, bacterial species or toxin families. Please see the attached RFI for a full list of performance objectives and information requested.